Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Segmentectomy Versus Lobectomy in Clinical T1c Non-Small Cell Lung Cancer: A Non-Inferiority Trial

NCT06646770 is registered in ClinicalTrials.gov with Istanbul University - Cerrahpasa as lead sponsor.

NCT NCT06646770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06646770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Segmentectomy Versus Lobectomy in Clinical T1c Non-Small Cell Lung Cancer: A Non-Inferiority Trial
Lead sponsor
Istanbul University - Cerrahpasa
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 2, 2025
Completion date
January 31, 2030
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer